Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Debt Ratio (2016 - 2025)

Abeona Therapeutics has reported Debt Ratio over the past 11 years, most recently at 0.09 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.09 for Q4 2025, down 47.58% from a year ago — trailing twelve months through Dec 2025 was 0.09 (down 47.58% YoY), and the annual figure for FY2025 was 0.09, down 47.58%.
  • Debt Ratio for Q4 2025 was 0.09 at Abeona Therapeutics, up from 0.09 in the prior quarter.
  • Over the last five years, Debt Ratio for ABEO hit a ceiling of 0.24 in Q1 2024 and a floor of 0.01 in Q1 2021.
  • Median Debt Ratio over the past 4 years was 0.15 (2024), compared with a mean of 0.14.
  • Peak annual rise in Debt Ratio hit 2060.05% in 2021, while the deepest fall reached 92.23% in 2021.
  • Abeona Therapeutics' Debt Ratio stood at 0.11 in 2021, then crashed by 38.77% to 0.06 in 2022, then soared by 168.52% to 0.17 in 2024, then plummeted by 47.58% to 0.09 in 2025.
  • The last three reported values for Debt Ratio were 0.09 (Q4 2025), 0.09 (Q3 2025), and 0.08 (Q2 2025) per Business Quant data.